Clinical Trials

Clinical Trials

If you are interested in participating in our research, please click here to take a brief survey.


Current Clinical Research Projects at our Clinic



Protocol: E2609-G000-302

Patients: 50 to 85 years old

Diagnostic: MCI/Alzheimer’s Disease

Agent: Beta amyloid cleaving enzyme inhibitor

Daily oral administration

Currently Enrolling: No


Protocol: TTP488-305
Patients: 50-85 years old
Diagnostic: Probable AD
Agent: Azeliragon
Daily Oral Administration
Currently Enrolling: Yes 

TauRx Therapeutics Ltd.

Protocol: TRx-237-039

Patients: <90 years old

Diagnostic: MCI/Early Alzheimer’s disease

Agent: Leuco-methylthioninium bis(hydromethanesulfonate) (LMTM)

Daily Oral Administration

Currently Enrolling: Startup Pending